Acer Therapeutics Inc. Stock
Equities
ACER
US00444P1084
Biotechnology & Medical Research
Latest transcript on Acer Therapeutics Inc.
Managers | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | Nov. 16 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 21-05-31 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | Nov. 16 |
Joshua Schafer
BRD | Director/Board Member | 53 | Nov. 16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.22% | 3 M€ | -.--% | - | |
0.22% | 1 M€ | +3.49% | - |
1st Jan change | Capi. | |
---|---|---|
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |